Traws Pharma, Inc.
TRAW
$1.44
-$0.09-5.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.92M | -8.48M | -123.14M | -4.98M | -4.18M |
| Total Depreciation and Amortization | 2.00K | 2.00K | 4.00K | 4.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.77M | 343.00K | 117.84M | 333.00K | 332.00K |
| Change in Net Operating Assets | 1.11M | -3.35M | -4.56M | 222.00K | -582.00K |
| Cash from Operations | -4.04M | -11.48M | -9.85M | -4.42M | -4.43M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -3.65M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -3.65M | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.98M | 0.00 | 14.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19.98M | 0.00 | 14.00M | -- | -- |
| Foreign Exchange rate Adjustments | -9.00K | 0.00 | -3.00K | -7.00K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.93M | -11.48M | 496.00K | -4.43M | -4.42M |